PRECIPIO, INC. Other Preferred Stock Dividends and Adjustments
PRECIPIO, INC. (PRPO) reported Other Preferred Stock Dividends and Adjustments of $3.34 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2022-03-30
- PRECIPIO, INC. other preferred stock dividends and adjustments for the quarter ending 2020-12-31 was $0.00.
- PRECIPIO, INC. other preferred stock dividends and adjustments for the quarter ending 2020-09-30 was $0.00.
- PRECIPIO, INC. other preferred stock dividends and adjustments for the quarter ending 2020-06-30 was $0.00.
- PRECIPIO, INC. other preferred stock dividends and adjustments for the quarter ending 2020-03-31 was $3.34M.
- PRECIPIO, INC. other preferred stock dividends and adjustments for fiscal 2020 was $3.34M.
- PRECIPIO, INC. other preferred stock dividends and adjustments for fiscal 2018 was $4.22M, a 66.04% decline from fiscal 2017.
- PRECIPIO, INC. other preferred stock dividends and adjustments for fiscal 2017 was $12.43M, a 774.19% increase from fiscal 2016.
- PRECIPIO, INC. other preferred stock dividends and adjustments for fiscal 2016 was $1.42M.
| Period end | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $3.34M 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $3.34M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.34M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $3.34M 10-Q · filed 2021-05-14 | |||
| 2018-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $374.00K derived: sum of 2 quarters · filed 2020-03-27 | $708.00K derived: sum of 3 quarters · filed 2020-03-27 | $4.22M 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $334.00K derived: sum of 2 quarters · filed 2019-11-13 | $3.85M 10-Q · filed 2019-11-13 | $7.27M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $334.00K 10-Q · filed 2019-08-09 | $3.85M 10-Q · filed 2019-08-09 | $7.27M derived: sum of 3 quarters · filed 2019-08-09 | $11.03M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $3.51M 10-Q · filed 2019-05-16 | $6.93M derived: sum of 2 quarters · filed 2019-05-16 | $10.70M derived: sum of 3 quarters · filed 2019-05-16 | $15.95M derived: sum of 4 quarters · filed 2019-05-16 |
| 2017-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | $7.18M derived: sum of 2 quarters · filed 2019-04-16 | $12.43M derived: sum of 3 quarters · filed 2019-04-16 | $12.43M 10-K · filed 2019-04-16 |
| 2017-09-30 | $3.76M 10-Q · filed 2018-11-19 | $9.01M derived: sum of 2 quarters · filed 2018-11-19 | $9.01M 10-Q · filed 2018-11-19 | |
| 2017-06-30 | $5.25M 10-Q · filed 2018-08-16 | $5.25M 10-Q · filed 2018-08-16 | ||
| 2016-12-31 | $1.42M 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |